These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 22628234
21. Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder. Kang ES, Min JH, Lee KH, Kim BJ. Ann Lab Med; 2012 Sep; 32(5):331-8. PubMed ID: 22950068 [Abstract] [Full Text] [Related]
22. Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry. Jarius S, Franciotta D, Paul F, Bergamaschi R, Rommer PS, Ruprecht K, Ringelstein M, Aktas O, Kristoferitsch W, Wildemann B. J Neurol Sci; 2012 Sep 15; 320(1-2):32-7. PubMed ID: 22705047 [Abstract] [Full Text] [Related]
23. Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica. Mader S, Lutterotti A, Di Pauli F, Kuenz B, Schanda K, Aboul-Enein F, Khalil M, Storch MK, Jarius S, Kristoferitsch W, Berger T, Reindl M. PLoS One; 2010 May 05; 5(5):e10455. PubMed ID: 20463974 [Abstract] [Full Text] [Related]
24. Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate. Jarius S, Paul F, Fechner K, Ruprecht K, Kleiter I, Franciotta D, Ringelstein M, Pache F, Aktas O, Wildemann B. J Neuroinflammation; 2014 Jul 29; 11():129. PubMed ID: 25074611 [Abstract] [Full Text] [Related]
25. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, Franciotta D, Bergamaschi R, Littleton E, Palace J, Seelig HP, Hohlfeld R, Vincent A, Zipp F. PLoS Med; 2007 Apr 29; 4(4):e133. PubMed ID: 17439296 [Abstract] [Full Text] [Related]
26. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F, Storch MK, Koson P, Drulovic J, Kristoferitsch W, Berger T, Reindl M. J Neuroinflammation; 2011 Dec 28; 8():184. PubMed ID: 22204662 [Abstract] [Full Text] [Related]
27. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia. Fabis-Pedrini MJ, Bundell C, Wee CK, Lucas M, McLean-Tooke A, Mastaglia FL, Carroll WM, Kermode AG. J Neuroimmunol; 2018 Nov 15; 324():76-80. PubMed ID: 30248527 [Abstract] [Full Text] [Related]
29. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese. Chan KH, Ramsden DB, Yu YL, Kwok KH, Chu AC, Ho PW, Kwan JS, Lee R, Lim E, Kung MH, Ho SL. Eur J Neurol; 2009 Mar 15; 16(3):310-6. PubMed ID: 19138340 [Abstract] [Full Text] [Related]
30. Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica. Kalluri SR, Illes Z, Srivastava R, Cree B, Menge T, Bennett JL, Berthele A, Hemmer B. Arch Neurol; 2010 Oct 15; 67(10):1201-8. PubMed ID: 20937947 [Abstract] [Full Text] [Related]
31. Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. Waters P, Reindl M, Saiz A, Schanda K, Tuller F, Kral V, Nytrova P, Sobek O, Nielsen HH, Barington T, Lillevang ST, Illes Z, Rentzsch K, Berthele A, Berki T, Granieri L, Bertolotto A, Giometto B, Zuliani L, Hamann D, van Pelt ED, Hintzen R, Höftberger R, Costa C, Comabella M, Montalban X, Tintoré M, Siva A, Altintas A, Deniz G, Woodhall M, Palace J, Paul F, Hartung HP, Aktas O, Jarius S, Wildemann B, Vedeler C, Ruiz A, Leite MI, Trillenberg P, Probst M, Saschenbrecker S, Vincent A, Marignier R. J Neurol Neurosurg Psychiatry; 2016 Sep 15; 87(9):1005-15. PubMed ID: 27113605 [Abstract] [Full Text] [Related]
32. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B, Geraldes R, Vale T, Jacob A, Palace J, Maxwell S, Beeson D, Vincent A. Arch Neurol; 2008 Jul 15; 65(7):913-9. PubMed ID: 18625857 [Abstract] [Full Text] [Related]
33. Role of AQP4 Antibody Serostatus and its Prediction of Visual Outcome in Neuromyelitis Optica: A Systematic Review and Meta-Analysis. Lin N, Liu Q, Wang X, Ma J, Li Y. Protein Pept Lett; 2017 Jul 15; 24(3):245-252. PubMed ID: 28071581 [Abstract] [Full Text] [Related]
34. Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificity. Pisani F, Sparaneo A, Tortorella C, Ruggieri M, Trojano M, Mola MG, Nicchia GP, Frigeri A, Svelto M. PLoS One; 2013 Jul 15; 8(11):e79185. PubMed ID: 24260168 [Abstract] [Full Text] [Related]
35. The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica. Yang Y, Huang DH, Wu WP, Wu L, Chen LF, Wu Q. J Clin Neurosci; 2013 Jan 15; 20(1):94-8. PubMed ID: 23142234 [Abstract] [Full Text] [Related]
37. Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients. Kishk NA, Abokrysha NT, Rashed L, Ahmed N. J Clin Neurosci; 2015 Apr 15; 22(4):670-5. PubMed ID: 25677878 [Abstract] [Full Text] [Related]
38. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J. Brain; 2007 May 15; 130(Pt 5):1206-23. PubMed ID: 17439988 [Abstract] [Full Text] [Related]
39. Comparative Analysis for the Presence of IgG Anti-Aquaporin-1 in Patients with NMO-Spectrum Disorders. Sánchez Gomar I, Díaz Sánchez M, Uclés Sánchez AJ, Casado Chocán JL, Suárez-Luna N, Ramírez-Lorca R, Villadiego J, Toledo-Aral JJ, Echevarría M. Int J Mol Sci; 2016 Jul 23; 17(8):. PubMed ID: 27455255 [Abstract] [Full Text] [Related]
40. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ. Arch Neurol; 2009 Sep 23; 66(9):1164-7. PubMed ID: 19752309 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]